Point72 Asset Management
ANRO icon

Point72 Asset Management’s Alto Neuroscience ANRO Stock Holding History

Point72 Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3M Sell
503,087
-1,103,867
-69% -$20.5M 0.01% 1158
2025
Q4 		$28.6M Buy
1,606,954
+274,517
+21% +$3.46M 0.03% 681
2025
Q3 		$5.36M Buy
1,332,437
+2,682
+0.2% +$8.89K 0.01% 1043
2025
Q2 		$2.93M Buy
1,329,755
+89,702
+7% +$213K 0.01% 1160
2025
Q1 		$2.68M Sell
1,240,053
-452,100
-27% -$1.62M 0.01% 1150
2024
Q4 		$7.16M Buy
1,692,153
+714,461
+73% +$4.46M 0.02% 827
2024
Q3 		$11.2M Sell
977,692
-72,345
-7% -$885K 0.03% 608
2024
Q2 		$11.2M Sell
1,050,037
-74,963
-7% -$976K 0.03% 566
2024
Q1 		$17.3M Buy
+1,125,000
New +$17.6M 0.04% 497

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management's ANRO Position: Q1 2026 in Review

Point72 Asset Management reduced its Alto Neuroscience (ANRO) stake by 69% in Q1 2026, selling an estimated $20.5M and leaving 503,087 shares worth $11.3M. The position accounts for 0.01% of the portfolio, ranked #1158.

Point72 Asset Management first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. The position peaked at $28.6M in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Point72 Asset Management held 503,087 shares of Alto Neuroscience worth $11.3M as of Q1 2026.
  • Point72 Asset Management sold 1,103,867 Alto Neuroscience shares in Q1 2026, an estimated $20.5M.
  • Alto Neuroscience made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1158 holding.
  • Point72 Asset Management first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
  • Point72 Asset Management's Alto Neuroscience position peaked at $28.6M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.